SCHEMBL4899060

SCHEMBL4899060

N[C@@H](CCC(=O)NCCCCO)C(=O)O

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OTC P00480 1/20 0.51
NOD1 Q9Y239 4/20 0.48
SLC1A2 P43004 2/20 0.47
SLC1A1 P43005 2/20 0.47
GSR P00390 2/20 0.47
GRM8 O00222 1/20 0.47
GRM6 O15303 1/20 0.47
GRIN2D O15399 1/20 0.47
GRIN3B O60391 1/20 0.47
CYP1A2 P05177 1/20 0.47
GRIK1 P39086 1/20 0.47
GRM5 P41594 1/20 0.47
GRIA1 P42261 1/20 0.47
GRIA2 P42262 1/20 0.47
GRIA3 P42263 1/20 0.47
SLC1A3 P43003 1/20 0.47
GRIA4 P48058 1/20 0.47
GRIN1 Q05586 1/20 0.47
GRIN2A Q12879 1/20 0.47
GRIK2 Q13002 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8627837 1.00 OTC (0.51) OTCNOD1SLC1A2SLC1A1GSR
SCHEMBL1372555 0.95 OTC (0.53) OTCNOD1SLC1A2SLC1A1GSR
SCHEMBL18637013 0.95 OTC (0.53) OTCNOD1SLC1A2SLC1A1GSR
SCHEMBL29486962 0.89 OTC (0.58) OTCNOD1SLC1A2SLC1A1GSR
SCHEMBL365299 0.89 OTC (0.58) OTCNOD1SLC1A2SLC1A1GSR
SCHEMBL10005285 0.89 OTC (0.58) OTCNOD1SLC1A2SLC1A1GSR
SCHEMBL1512875 0.87 SLC1A1 (0.52) OTCNOD1SLC1A2SLC1A1GSR
SCHEMBL1374853 0.87 SLC1A1 (0.52) OTCNOD1SLC1A2SLC1A1GSR
SCHEMBL27776403 0.86 GSR (0.58) OTCNOD1SLC1A2SLC1A1GSR
SCHEMBL1116103 0.86 GSR (0.58) OTCNOD1SLC1A2SLC1A1GSR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080003288-A1 Responsive microgel and methods related thereto SUPRATEK PHARMA INC. (CA) 2008-01-03 US disclosed
US-7204997-B2 Responsive microgel and methods related thereto SUPRATEK PHARMA INC. (CA) 2007-04-17 US disclosed
EP-1478403-A1 RESPONSIVE MICROGEL AND METHODS RELATED THERETO SUPRATEK PHARMA, INC. (CA) 2004-11-24 EP disclosed
US-20030152623-A1 Responsive microgel and methods related thereto SUPRATEK PHARMA INC. (CA) 2003-08-14 US disclosed
WO-2003063909-A1 RESPONSIVE MICROGEL AND METHODS RELATED THERETO SUPRATEK PHARMA INC. (US) 2003-08-07 WO disclosed
EP-0910351-A1 PARTICLES COMPRISING AMPHIPHILIC COPOLYMERS, HAVING A CROSS-LINKED SHELL DOMAIN AND AN INTERIOR CORE DOMAIN, USEFUL FOR PHARMACEUTICAL AND OTHER APPLICATIONS G.D. Searle & Co. (US) 1999-04-28 EP disclosed
EP-0907666-A1 PARTICLES COMPRISING AMPHIPHILIC COPOLYMERS, HAVING A CROSS-LINKED SHELL DOMAIN AND AN INTERIOR CORE DOMAIN, USEFUL FOR PHARMACEUTICAL AND OTHER APPLICATIONS G.D. Searle & Co. (US) 1999-04-14 EP disclosed
US-5834431-A Des-Arg9 -BK antagonists CORTECH, INC. (US) 1998-11-10 US disclosed
EP-0848718-A1 CYTOLYTIC BRADYKININ ANTAGONISTS CORTECH, INC. (US) 1998-06-24 EP disclosed
WO-1997049736-A2 PARTICLES COMPRISING AMPHIPHILIC COPOLYMERS, HAVING A CROSS-LINKED SHELL DOMAIN AND AN INTERIOR CORE DOMAIN, USEFUL FOR PHARMACEUTICAL AND OTHER APPLICATIONS G.D. SEARLE AND CO. (US) 1997-12-31 WO disclosed
WO-1997049387-A1 PARTICLES COMPRISING AMPHIPHILIC COPOLYMERS, HAVING A CROSS-LINKED SHELL DOMAIN AND AN INTERIOR CORE DOMAIN, USEFUL FOR PHARMACEUTICAL AND OTHER APPLICATIONS G.D. SEARLE AND CO. (US) 1997-12-31 WO disclosed
WO-1997009347-A1 CYTOLYTIC BRADYKININ ANTAGONISTS CORTECH, INC. (US) 1997-03-13 WO disclosed
WO-1997009346-A1 DES-ARG9-BK ANTAGONISTS CORTECH, INC. (US) 1997-03-13 WO disclosed
WO-1996016081-A1 BRADYKININ ANTAGONIST PEPTIDES CONTAINING INDANE-SUBSTITUTED AMINO ACIDS UNIVERSITY TECHNOLOGY CORPORATION (US) 1996-05-30 WO disclosed